Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Nitrosamine

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dipharma Introduces Method To Detect Nitrosamine formation APIs
    Dipharma Introduces Method To Detect Nitrosamine formation APIs

    27 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/27/3195924/0/en/Dipharma-publishes-a-peer-reviewed-study-in-Organic-Process-Research-Development-a-novel-approach-to-detect-and-characterize-nitrosamine-formation-in-APIs.html

    GLOBENEWSWIRE
    27 Nov 2025
    Share Share
    Piramal Pharma Solutions Ensures Nitrosamine Impurity Compliance
    Piramal Pharma Solutions Ensures Nitrosamine Impurity Compliance

    27 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-pharma-solutions-achieves-regulatory-compliance-for-nitrosamine-impurities-302627042.html

    PR NEWSWIRE
    27 Nov 2025
    Share Share
    FDA Urges Pharma Companies To Finish Nitrosamine Risk Assessments
    FDA Urges Pharma Companies To Finish Nitrosamine Risk Assessments

    27 Oct 2025

    // RAPS

    https://www.raps.org/news-and-articles/news-articles/2025/10/fda-s-top-generic-drug-official-urges-firms-to-com

    RAPS
    27 Oct 2025
    Share Share
    FDA Lists Its Upcoming Research Priorities For Generic Drugs
    FDA Lists Its Upcoming Research Priorities For Generic Drugs

    01 Oct 2025

    // RAPS

    https://www.raps.org/news-and-articles/news-articles/2025/10/fda-lists-its-upcoming-research-priorities-for-gen

    RAPS
    01 Oct 2025
    Share Share
    Swissmedic mandates nitrosamine risk assessments in applications
    Swissmedic mandates nitrosamine risk assessments in applications

    08 May 2025

    // RAPS

    https://www.raps.org/news-and-articles/news-articles/2025/5/euro-roundup-swissmedic-mandates-nitrosamine-risk

    RAPS
    08 May 2025
    Share Share
    FDA declines to approve Milestone's heart rhythm nasal spray
    FDA declines to approve Milestone's heart rhythm nasal spray

    29 Mar 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-milestone-pharmas-heart-rhythm-nasal-spray-2025-03-28/

    REUTERS
    29 Mar 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.